Adacolumn.com
JIMRO
Top page
Press Release
Method
Preclinical
Clinical trial
Quality of life
Package insert
Literature
Case Report
Inquire
Associated companies
JIMRO.com

Interview Report > -Treatment for UC and CD in Sweden-


  1. Do you have a treatment guideline in Sweden? If so, would you please explain what it is and how it works? What kind of drugs or medical treatment do you offer UC and CD patients?

    There is a general guideline (pyramid system; fig, 1) but perhaps not as organized as that in Japan. We start to treat patients in Sweden with the mildest type of medications like 5-ASA (Asacol, Dipentum), or Salazopyrin for UC, and metronidazole (Flagyl) or budesonide (Entecort, a topical steroid) for CD. 5-ASA is not used much for CD in Sweden because there is little evidence that it works in CD. Then there is prednisolone for moderately active UC and CD. If that does not work, then we use the immunomodulators (IMM) like azathioprine (AZ) or 6-mercaptopurine (6-MP). If that fails, we sometimes use Infliximab (Remicade) but only for CD. However, Infliximab may be associated with serious side effects like opportunistic infections, sometimes lethal. At the same level, we have the Adacolumn for UC. Unlike Japan, we never use cyclosporine A (CyA) in Sweden because it is associated with many long-term problems and ultimately, patients treated with CyA usually will have a colectomy anyhow. For maintenance therapy, we use 5-ASA or sulfasalazine for UC and, AZ or 6-MP for CD. AZ has become a drug of choice for CD, and if treated optimally with AZ, many CD patients can avoid Infliximab. So we always start with AZ before going to Infliximab. Moreover, in Scandinavia at least, there is no increase in mortality in IBD patients compared to the general population, so we must be very careful with using potentially toxic drugs which could induce serious adverse events including for example, severe infections and lymphoma in these patients.


  2. Which medicine is used for outpatient treatment?

    In general, fewer and fewer patients are treated as in-patients. Most IBD patients are treated as out-patients in Daycare units or IBD out-patient units. Only IBD patients with a severe attack of disease or in need of surgery are treated as in-patients. IBD patients visit their doctors about once every 4 weeks during active disease stage, while during inactive stage, they visit their doctors about 1-2/year.

  3. Do you give elemental diet in Sweden?

    We rarely use elemental diet (ED) in Sweden. ED is more of a supplement for some patients. It is also used as a pre-operative diet, especially total parenteral nutrition (TPN). TPN given intravenously is more commonly used pre-operatively compared to enteral diet.

  4. How is extracorporeal apheresis system used in Sweden?

    We have just started the Adacolumn in Sweden. We are the first to use the Adacolumn in a broad scale outside Japan. It has just been introduced in Sweden. The results are very promising.

  5. Please tell me about surgery for UC and CD patients in Sweden? When do you think surgery is suitable?

    I think we are liberal with surgery in Sweden. If a patient has chronic active disease, we would rather opt for surgery rather than toxic drugs. In UC, we have the pelvic pouch type of operation (ileoanal anastomosis) which is a good alternative in chronic active disease or severe colitis. The procedure was first performed in Sweden in 1980, so we have 22 years of experience. We also perform surgery early for CD patients, by making small directed resections because patients are doing well (could be well for up to 10 years without medications) after this small resection procedure. However, there is a need for close collaboration between the gastroenterologists and surgeons all the time to decide the best option for the particular patients. The number of colectomy is decreasing; fewer and fewer patients are undergoing major operation such as colectomy these days.

    Top

    Circumstances of CD and UC patients
    General Information


    Interview Report



Copyright (C) JIMRO Co,.Ltd. All Rights Reserved.